MDP — Medexus Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$62.12m
- CA$115.09m
- $113.05m
- 60
- 94
- 79
- 92
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -4.7 | -28.3 | -2.88 | 1.22 | -0.214 |
Depreciation | |||||
Amortisation | |||||
Deferred Taxes | |||||
Non-Cash Items | 2.61 | 32 | -8.49 | 7.43 | 12.2 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -2.04 | -0.688 | 4.05 | -16.2 | 0.921 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.73 | 5.04 | -1.18 | -1.44 | 18.7 |
Capital Expenditures | -0.897 | -10.8 | -7.71 | -0.362 | -0.266 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -29.4 | -0.949 | -0.482 | -1.36 | -3.21 |
Acquisition of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -30.3 | -11.7 | -8.2 | -1.72 | -3.48 |
Financing Cash Flow Items | -1.43 | -3.93 | -3.07 | -4.33 | -4.25 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 15.4 | 18.7 | 0.663 | 6.41 | -23 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -16.6 | 13.5 | -8.69 | 3.05 | -7.81 |